| 产品描述: | CPDA is a novel potent SH2 domain-containing inositol phosphatase 2 (SHIP2) inhibitor. |
| 靶点: |
SHIP2;Phosphatase |
| 体外研究: |
CPDA enhances insulin signaling. |
| 体内研究: |
CPDA greatly improves abnormal glucose metabolism in diabetic animals. CPDA improves the abnormal glucose metabolism in db/db mice. |
| 参考文献: |
1. Rational design and synthesis of 4-substituted 2-pyridin-2-ylamides with inhibitory effects on SH2 domain-containing inositol 5'-phosphatase 2 (SHIP2). Eur J Med Chem. 2013 Apr;62:649-660. |
| 溶解性: |
soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.572 ml |
12.86 ml |
25.72 ml |
| 5 mM |
0.514 ml |
2.572 ml |
5.144 ml |
| 10 mM |
0.257 ml |
1.286 ml |
2.572 ml |
| 50 mM |
0.051 ml |
0.257 ml |
0.514 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |